SynthesisDrugs & aging2020

Immune Checkpoint Inhibitors for Patients Aged ≥ 75 Years with Advanced Cancer in First- and Second-Line Settings: A Meta-Analysis.

Thierry Landre et al.PubMed ↗Publisher ↗

No numbers read from the abstract.